Product correctly added to cart.

discount label
RS 25344 hydrochloride
View 3D

Biosynth logo

RS 25344 hydrochloride

CAS: 152815-28-6

Ref. 3D-CGA81528

5mgTo inquire
10mgTo inquire
25mgTo inquire
50mgTo inquire
100mgTo inquire
Estimated delivery in United States, on Thursday 16 Jan 2025

Product Information

Name:
RS 25344 hydrochloride
Description:

RS 25344 hydrochloride is a selective and activating phosphoinositide 3-kinase (PI3K) inhibitor. It has been shown to selectively inhibit the PI3K pathway, which is involved in cancer development and progression. RS 25344 hydrochloride induces cancer stem cells by inhibiting the activation of protein kinase B (Akt), which plays an important role in cell proliferation, differentiation, and apoptosis. In addition, this drug inhibits mesenchymal-epithelial transition by blocking the activation of the protein kinase C alpha (PKCα), which is involved in epithelial-mesenchymal transition. RS 25344 hydrochloride also induces cancer cells to transition from a stem cell phenotype into a non-stem cell phenotype by inhibiting the function of protein kinase A (PKA).

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
411.8 g/mol
Formula:
C19H14ClN5O4
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-CGA81528 RS 25344 hydrochloride

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".